IMNM: Immunome Inc Kompaniya qiymatining sof foydaga nisbati
Immunome, Inc. (IMNM) noyob immunitet tahlili tizimidan foydalangan holda AQSh laboratoriyalarida o'simtaga qarshi dori vositalarini ishlab chiqadi. GURU.Markets platformasida joriy P/E ko'paytirgichi aktivlar qiymati dinamikasini vizuallashtiradi, bunda ko'rsatkich -7.60 darajasida qat'iy belgilangan. Samarali boshqaruv yangi resurslarni muvaffaqiyatli integratsiya qilmoqda va sog'liqni saqlash gigantlari bilan daromadli kelishuvlarni ta'minlamoqda. B-hujayralardan antitanalarni ajratish bo'yicha patentlar texnologik ustunlikni taqdim etadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_IMNM_-_Immunome-Inc._-_PE-Multiple "IMNM: Immunome, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
Immunome Corp (IMNM) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Immunome Bio|IMNM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunome, Inc.|IMNM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Immunome|Oraliq qoplama koeffitsiyenti immunome.com
- foyda va bozor multiplikatorlari tafsilotlari:
IMNM - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunome, Inc.|IMNM - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Immunome Inc|IMNM - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Immunome, Inc.|IMNM - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Immunome|IMNM - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi immunome.com|IMNM - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Immunome, Inc.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:immunome.com IMNM
Immunome, Inc. (IMNM) onkologiya va virusli terapiyalar uchun yuqori texnologiyali antitelalarni kashf qilish platformasini ishlab chiqmoqda va maqsadlarni aniqlash uchun bemorlarning real dunyo ma'lumotlaridan foydalanmoqda. P/E bozor baholash metriki uchun -7.60 ning joriy qiymati aksiyalar narxlarining sof foydaga nisbatini aks ettiradi, bu esa investorlarga aktivlarning haddan tashqari qiziganini aniqlash va qiymati biznesning haqiqiy daromadlaridan tezroq o'sadigan toksik qimmatqaymolarni sotib olishdan qochish imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tourmaline TRML|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti pharming.com|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narx-foyda koeffitsiyenti Upstream Bio, Inc. (UPB)|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|P/E multiplikatori Gossamer Bio Corp. (GOSS)|Narxning foydaga nisbati KalVista Pharmaceuticals KALV|SEPN: Narx-foyda multiplikatori|PVLA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Savara Inc|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti AnaptysBio Inc.|ATXS (Astria Therapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati engene.com ENGN|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris)|Biznesning o‘zini qoplash muddati Kyverna Therapeutics, Inc (KYTX)|TLSA - Narxning foydaga nisbati|CABA (cabalettabio.com) - Narx-foyda multiplikatori|VTYX: P/E multiplikatori|Narx-foyda koeffitsiyenti Theratechnologies, Inc.|Narx-foyda koeffitsiyenti AVTX|Eledon Pharmaceuticals, Inc (ELDN) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AGEN|Biznesning o‘zini qoplash muddati climbbio.com|Narxning foydaga nisbati Zura Bio ZURA|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA (ImageneBio Inc) - Narx-foyda multiplikatori|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Equillium|Narxning foydaga nisbati Connect Biopharma Holdings|Immunic Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATRA|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|CELU - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - P/E multiplikatori|P/E multiplikatori akaritx.com|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Biznesning o‘zini qoplash muddati Edesa Biotech Corp (EDSA)|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|Narx-foyda koeffitsiyenti HCWB|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|aditxt.com - Narx-foyda multiplikatori|P/E multiplikatori GRI (GRI Bio)|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning foydaga nisbati|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|OCEA - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
